Latest Pharmaceutical manufacturing News

NOT REAL NEWS: A look at what didn't happen this week

Sep. 23, 2022 10:52 AM EDT

A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: ___ Ad misleads on treaty regulating...

Gates Foundation prods UN, honors inspiration as Goalkeepers

Sep. 21, 2022 19:44 PM EDT

NEW YORK (AP) — Bill Gates and Melinda French Gates combined characteristic optimism with sobering questions about persistent gender inequality and hunger at an event focused on reaching global development goals that the Gateses' foundation convened on the sidelines of the U.N. General Assembly. ...

Bristol-Myers, Gilead rise, SVB Financial, BioMarin fall

Sep. 12, 2022 16:30 PM EDT

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday: Bristol-Myers Squibb Co., up $2.20 to $72.36. The pharmaceutical company received U.S. approval for a psoriasis treatment. Gilead Sciences Inc., up $2.73 to $68.01. ...

FDA panel backs much-debated ALS drug in rare, 2nd review

Sep. 07, 2022 19:23 PM EDT

WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year. The Food...

Biden touts legislative record as midterms approach

Sep. 06, 2022 17:20 PM EDT

WASHINGTON (AP) — President Joe Biden ended the summer on a legislative winning streak, chalking up victories that once appeared out of reach in this polarized capital. Now he wants to make sure voters reward him for that when they cast ballots in November's big congressional elections. ...

India and China clear needle-free COVID-19 vaccines

Sep. 06, 2022 11:24 AM EDT

NEW DELHI (AP) — India and China have cleared a new approach in COVID-19 vaccination — two needle-free options, one a squirt in the nose and the other inhaled through the mouth. Regulators in India authorized Bharat Biotech's nasal version on Tuesday as an option for people who...

FDA still skeptical of ALS drug ahead of high-stakes meeting

Sep. 02, 2022 17:11 PM EDT

WASHINGTON (AP) — Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease, even as they prepare to give its drugmaker a rare second opportunity to make a public case for the treatment. ...

Limited funding hampers charities’ early monkeypox response

Sep. 01, 2022 09:22 AM EDT

Two biopharmaceutical companies will give $5 million and $500,000, respectively, to nonprofit organizations in the United States and abroad that are responding to the growing monkeypox outbreak. The pledges come as the early philanthropic response to the disease, which disproportionately affects...

Florida sues FDA over 'delay' of low-cost drug importations

Aug. 31, 2022 13:56 PM EDT

TALLAHASSEE, Fla. (AP) — Florida sued federal health officials on Wednesday, accusing them of stalling the state's plan to import lower-cost prescription drugs from Canada. Republican Gov. Ron DeSantis announced the lawsuit against the U.S. Department of Health and Human Services...

EXPLAINER: Lower prescription prices to take time in new law

Aug. 27, 2022 11:17 AM EDT

WASHINGTON (AP) — After decades of failed attempts, Democrats passed legislation that aims to rein in the soaring costs of drugs for some in the United States. It will take years for people to realize some of the most significant savings promised in the climate and health care bill...